Iron metabolism and the role of HFE gene polymorphisms in Wilson disease

Liver International

Volumn 32, Issue 1, 2012, Pages 165-170

  Pfeiffenberger, Jan ^a   Gotthardt, Daniel N ^a   Herrmann, Thomas ^a,b   Seeßle, Jessica ^a   Merle, Uta ^a   Schirmacher, Peter ^a   Stremmel, Wolfgang ^a   Weiss, Karl Heinz ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Klinikum Idar Oberstein GmbH   (Germany)

Author keywords

ATP7B; HFE gene; Iron processing; Liver disease; Wilson disease

Indexed keywords

CERULOPLASMIN; FERRITIN; HFE PROTEIN; IRON;

ADULT; ARTICLE; CLINICAL FEATURE; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; IRON METABOLISM; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; WILSON DISEASE;

ADOLESCENT; BIOPSY; CERULOPLASMIN; FEMALE; FERRITINS; GENE FREQUENCY; HEPATOLENTICULAR DEGENERATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; LIVER; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; POLYMORPHISM, GENETIC; SEX FACTORS; YOUNG ADULT;

EID: 83255176766     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02661.x     Document Type: Article

References (37)

1. Stremmel W, Meyerrose KW, Niederau C et al. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 1991; 115: 720-6.
2. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 1995; 9: 210-7.
3. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993; 5: 327-37.
4. Cox DW. Molecular advances in Wilson disease. Prog Liver Dis 1996; 14: 245-64.
5. Fox PL. The copper-iron chronicles: the story of an intimate relationship. Biometals 2003; 16: 9-40.
6. Ryden L, Eaker D. Identification of the thiol groups in human ceruloplasmin. Eur J Biochem 1983; 132: 241-7.
7. Nakamura K, Endo F, Ueno T, et al. Excess copper and ceruloplasmin biosynthesis in long-term cultured hepatocytes from Long-Evans Cinnamon (LEC) rats, a model of Wilson disease. J Biol Chem 1995; 270: 7656-60.
8. Scheinberg IH, Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science 1952; 116: 484-5.
9. Macintyre G, Gutfreund KS, Martin WR, Camicioli R, Cox DW. Value of an enzymatic assay for the determination of serum ceruloplasmin. J Lab Clin Med 2004; 144: 294-301.
10. Merle U, Eisenbach C, Weiss KH, Tuma S, Stremmel W. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease. J Hepatol 2009; 51: 925-30.
11. Merle U, Tuma S, Herrmann T. Evidence for a critical role of ceruloplasmin oxidase activity in iron metabolism of Wilson disease gene knockout mice. J Gastroenterol Hepatol 2010; 25: 1144-50.
12. Chen H, Attieh ZK, Gao H, et al. Age-related changes in iron homeostasis in mouse ferroxidase mutants. Biometals 2009; 22: 827-34.
13. Chase MS, Gubler CJ, Cartwright GE, Wintrobe MM. Studies on copper metabolism. IV. The influence of copper on the absorption of iron. J Biol Chem 1952; 199: 757-63.
14. Gubler CJ, Lahey ME, Chase MS, Cartwright GE, Wintrobe MM. Studies on copper metabolism. III. The metabolism of iron in copper deficient swine. Blood 1952; 7: 1075-92.
15. Chase MS, Gubler CJ, Cartwright GE, Wintrobe MM. Studies on copper metabolism. V. Storage of iron in liver of copper-deficient rats. Proc Soc Exp Biol Med 1952; 80: 749-51.
16. Kato J, Kohgo Y, Sugawara N, et al. Abnormal hepatic iron accumulation in LEC rats. Jpn J Cancer Res 1993; 84: 219-22.
17. Shiono Y, Wakusawa S, Hayashi H, et al. Iron accumulation in the liver of male patients with Wilson's disease. Am J Gastroenterol 2001; 96: 3147-51.
18. Hayashi H, Yano M, Fujita Y, Wakusawa S. Compound overload of copper and iron in patients with Wilson's disease. Med Mol Morphol 2006; 39: 121-6.
19. Medici V, Di Leo V, Lamboglia F, et al. Effect of penicillamine and zinc on iron metabolism in Wilson's disease. Scand J Gastroenterol 2007; 42: 1495-500.
20. Olynyk JK, Cullen DJ, Aquilia S, et al. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341: 718-24.
21. Hafkemeyer P, Schupp M, Storch M, Gerok W, Haussinger D. Excessive iron storage in a patient with Wilson's disease. Clin Invest 1994; 72: 134-6.
22. Walshe JM, Cox DW. Effect of treatment of Wilson's disease on natural history of haemochromatosis. Lancet 1998; 352: 112-3.
23. Sorbello O, Sini M, Civolani A, Demelia L. HFE gene mutations and Wilson's disease in Sardinia. Dig Liver Dis 2009; 42: 216-9.
24. Erhardt A, Hoffmann A, Hefter H, Haussinger D. HFE gene mutations and iron metabolism in Wilson's disease. Liver 2002; 22: 474-8.
25. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003; 23: 139-42.
26. Gehrke SG, Stremmel W, Mathes I, et al. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype. J Mol Med 2003; 81: 780-7.
27. Searle J, Crawford LB, Powell LW. Iron storage diseases, In: MacSween RNM AP, Scheuer PJ, Portman BC, Burt AD, Ishak KG, eds. Pathology of the Liver, London, UK: Churchill Livinstone, 2002; 257-272.
28. Harris ED. The iron-copper connection: the link to ceruloplasmin grows stronger. Nutr Rev 1995; 53: 170-3.
29. Rivera-Mancia S, Perez-Neri I, Rios C, et al. The transition metals copper and iron in neurodegenerative diseases. Chem Biol Interact 2010; 186: 184-99.
30. Tapryal N, Mukhopadhyay C, Das D, Fox PL, Mukhopadhyay CK. Reactive oxygen species regulate ceruloplasmin by a novel mRNA decay mechanism involving its 3′-untranslated region: implications in neurodegenerative diseases. J Biol Chem 2009; 284: 1873-83.
31. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275-8.
32. Mukhopadhyay CK, Attieh ZK, Fox PL. Role of ceruloplasmin in cellular iron uptake. Science 1998; 279: 714-7.
33. Miyajima H, Takahashi Y, Kono S. Aceruloplasminemia, an inherited disorder of iron metabolism. Biometals 2003; 16: 205-13.
34. Lowette KF, Desmet K, Witters P, et al. Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine. Eur J Gastroenterol Hepatol 2010; 22: 564-71.
35. Weiss KH, Gottthardt DN, Klemm D, et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology 2011; 140: 1189-98.
36. Kowdley KV, Brandhagen DJ, Gish RG, et al. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. Gastroenterology 2005; 129: 494-503.
37. McLaren GD, Gordeuk VR. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Hematology Am Soc Hematol Educ Program 2009; 195-206.